Purchases and Sales Made in Q4 2023 in Puma Biotechnology, Inc. (PBYI)
This table provides information about the institutional ownership of Puma Biotechnology, Inc. (PBYI) during Q4 2023. The information is specifically focused on institutions that hold shares of PUMA BIOTECHNOLOGY, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-1.53K- 4.14% |
$3.41K - $6.87K
|
35.4K
$127K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.63K- 36.76% |
$3.63K - $7.31K
|
2.8K
$10K
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-1.96K- 10.17% |
$4.37K - $8.8K
|
17.3K
$62K
|
|
|
Feb 09, 2024
Q4 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-3.11K- 1.56% |
$6.93K - $14K
|
197K
$704K
|
|
|
Feb 16, 2024
Q4 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-17.3K- 6.18% |
$38.6K - $77.6K
|
262K
$939K
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-20.4K- 11.21% |
$45.5K - $91.6K
|
162K
$578K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-21.3K- 43.92% |
$47.5K - $95.6K
|
27.2K
$97.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-24K- 16.17% |
$53.5K - $108K
|
124K
$445K
|
|
|
Jan 19, 2024
Q4 2023
|
Patriot Financial Group Insurance Agency, LLC
|
SELL
|
- |
-32.5K- 48.51% |
$72.5K - $146K
|
34.5K
$124K
|
|
|
Feb 08, 2024
Q4 2023
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-33.8K- 9.29% |
$75.4K - $152K
|
330K
$1.18M
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-53.4K- 3.09% |
$119K - $240K
|
1.67M
$5.99M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-58.3K- 32.38% |
$130K - $262K
|
122K
$436K
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-62.6K- 68.79% |
$140K - $281K
|
28.4K
$102K
|
|
|
Feb 14, 2024
Q4 2023
|
Camber Capital Management LP
Boston, MA |
SELL
|
- |
-1.43M- 33.77% |
$3.19M - $6.42M
|
2.81M
$10M
|